Lurie Children's Hospital of Chicago Developmental Therapeutics — Chicago, Illinois

Lurie Children's Hospital of Chicago Developmental Therapeutics is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Lurie Children's Hospital of Chicago Developmental Therapeutics has participated in 6 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Solid Tumor, Hematologic Malignancies.

Sponsors: Novartis Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lurie Children's Hospital of Chicago Developmental Therapeutics?

Lurie Children's Hospital of Chicago Developmental Therapeutics has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lurie Children's Hospital of Chicago Developmental Therapeutics conducted?

Lurie Children's Hospital of Chicago Developmental Therapeutics has 6 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Solid Tumor, Hematologic Malignancies.

Is Lurie Children's Hospital of Chicago Developmental Therapeutics accredited by Crixeo Clinical Trials?

Lurie Children's Hospital of Chicago Developmental Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lurie Children's Hospital of Chicago Developmental Therapeutics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.